3-Hydroxytanshinone Inhibits the Activity of Hypoxia-Inducible Factor 1-α by Interfering with the Function of α-Enolase in the Glycolytic Pathway
Molecules · 2024
DOI: 10.3390/molecules29102218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Tae Hyun Son und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Phosphopyruvate Hydratase, Glycolysis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Forest Biomaterials Research Center of the National Institute of Forest Science, Forest Biomaterials Research Center of the National Institute of Forest Science.
Abstract (Originalsprache)
Tumor cells in hypoxic conditions control cancer metabolism and angiogenesis by expressing HIF-1α. Tanshinone is a traditional Chinese medicine that has been shown to possess antitumor properties and exerts a therapeutic impact on angiogenesis. However, the precise molecular mechanism responsible for the antitumor activity of 3-Hydroxytanshinone (3-HT), a type of tanshinone, has not been fully understood. Therefore, our study aimed to investigate the mechanism by which 3-HT regulates the expression of HIF-1α. Our findings demonstrate that 3-HT inhibits HIF-1α activity and expression under hypoxic conditions. Additionally, 3-HT inhibits hypoxia-induced angiogenesis by suppressing the expression of VEGF. Moreover, 3-HT was found to directly bind to α-enolase, an enzyme associated with glycolysis, resulting in the suppression of its activity. This inhibition of α-enolase activity by 3-HT leads to the blockade of the glycolytic pathway and a decrease in glycolysis products, ultimately altering HIF1-α expression. Furthermore, 3-HT negatively regulates the expression of HIF-1α by altering the phosphorylation of AMP-activated protein kinase (AMPK). Our study’s findings elucidate the mechanism by which 3-HT regulates HIF-1α through the inhibition of the glycolytic enzyme α-enolase and the phosphorylation of AMPK. These results suggest that 3-HT holds promise as a potential therapeutic agent for hypoxia-related angiogenesis and tumorigenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.
- Forest Biomaterials Research Center, National Institute of Forest Science (NIFoS), Jinju 52817, Republic of Korea.
- Department of Biological Sciences, Jeonbuk National University, Jeonju 54896, Republic of Korea.
ORCID-Profile: Shin-Hye Kim, Sik-Won Choi
Förderung
- the Forest Biomaterials Research Center of the National Institute of Forest Science
- Forest Biomaterials Research Center of the National Institute of Forest Science
Zitieren
APA
Son, T. H., Kim, S. H., Shin, H. L., Kim, D., Kim, H. G., Choi, Y., & Choi, S. W. (2024). 3-Hydroxytanshinone Inhibits the Activity of Hypoxia-Inducible Factor 1-α by Interfering with the Function of α-Enolase in the Glycolytic Pathway. Molecules. https://doi.org/10.3390/molecules29102218
Vancouver
Son TH, Kim SH, Shin HL, Kim D, Kim HG, Choi Y, et al. 3-Hydroxytanshinone Inhibits the Activity of Hypoxia-Inducible Factor 1-α by Interfering with the Function of α-Enolase in the Glycolytic Pathway. Molecules. 2024. doi:10.3390/molecules29102218
BibTeX
@article{Son2024,
author = {Son, Tae Hyun and Kim, Shin-Hye and Shin, Hye-Lim and Kim, Dongsoo and Kim, Hwan Gyu and Choi, Yongseok and Choi, Sik-Won},
title = {3-Hydroxytanshinone Inhibits the Activity of Hypoxia-Inducible Factor 1-α by Interfering with the Function of α-Enolase in the Glycolytic Pathway},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29102218}
}
EUVIMED